Cargando…
Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
OBJECTIVE: The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF). SETTING: A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665875/ https://www.ncbi.nlm.nih.gov/pubmed/34908840 http://dx.doi.org/10.2147/TCRM.S340587 |
_version_ | 1784614099122913280 |
---|---|
author | Lan, Tian Liao, Yan-Hui Zhang, Jian Yang, Zhi-Ping Xu, Gao-Si Zhu, Liang Fan, Dai-Ming |
author_facet | Lan, Tian Liao, Yan-Hui Zhang, Jian Yang, Zhi-Ping Xu, Gao-Si Zhu, Liang Fan, Dai-Ming |
author_sort | Lan, Tian |
collection | PubMed |
description | OBJECTIVE: The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF). SETTING: A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate the pooled results. PARTICIPANTS: A total of 27 studies with 515,238 participants were finally meta-analysed. The HF patients had an average age of 76.3 years, with 51% of the sample being male, in the pooled analysis. PRIMARY AND SECONDARY OUTCOME MEASURES: The outcome measures were 30-day and 1-year readmission rates, mortality, and risk factors for readmission and mortality. RESULTS: The effect sizes for readmission and mortality were estimated as the mean and 95% confidence interval (CI). The estimated 30-day and 1-year all-cause readmission rates were 0.19 (95% CI 0.14–0.23) and 0.53 (95% CI 0.46–0.59), respectively, while the all-cause mortality rates were 0.14 (95% CI 0.10–0.18) and 0.29 (95% CI 0.25–0.33), respectively. Comorbidities were highly prevalent in individuals with HF. CONCLUSION: Heart failure hospitalization is followed by high readmission and mortality rates. |
format | Online Article Text |
id | pubmed-8665875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-86658752021-12-13 Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis Lan, Tian Liao, Yan-Hui Zhang, Jian Yang, Zhi-Ping Xu, Gao-Si Zhu, Liang Fan, Dai-Ming Ther Clin Risk Manag Review OBJECTIVE: The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF). SETTING: A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate the pooled results. PARTICIPANTS: A total of 27 studies with 515,238 participants were finally meta-analysed. The HF patients had an average age of 76.3 years, with 51% of the sample being male, in the pooled analysis. PRIMARY AND SECONDARY OUTCOME MEASURES: The outcome measures were 30-day and 1-year readmission rates, mortality, and risk factors for readmission and mortality. RESULTS: The effect sizes for readmission and mortality were estimated as the mean and 95% confidence interval (CI). The estimated 30-day and 1-year all-cause readmission rates were 0.19 (95% CI 0.14–0.23) and 0.53 (95% CI 0.46–0.59), respectively, while the all-cause mortality rates were 0.14 (95% CI 0.10–0.18) and 0.29 (95% CI 0.25–0.33), respectively. Comorbidities were highly prevalent in individuals with HF. CONCLUSION: Heart failure hospitalization is followed by high readmission and mortality rates. Dove 2021-12-07 /pmc/articles/PMC8665875/ /pubmed/34908840 http://dx.doi.org/10.2147/TCRM.S340587 Text en © 2021 Lan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Lan, Tian Liao, Yan-Hui Zhang, Jian Yang, Zhi-Ping Xu, Gao-Si Zhu, Liang Fan, Dai-Ming Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis |
title | Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis |
title_full | Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis |
title_fullStr | Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis |
title_short | Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis |
title_sort | mortality and readmission rates after heart failure: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665875/ https://www.ncbi.nlm.nih.gov/pubmed/34908840 http://dx.doi.org/10.2147/TCRM.S340587 |
work_keys_str_mv | AT lantian mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis AT liaoyanhui mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis AT zhangjian mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis AT yangzhiping mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis AT xugaosi mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis AT zhuliang mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis AT fandaiming mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis |